Frontier Capital Management CO LLC United Therapeutics Corp Transaction History

Frontier Capital Management CO LLC

$9.96 Billion
Q3 2024

A detailed history of Frontier Capital Management CO LLC transactions in United Therapeutics Corp stock. As of the latest transaction made, Frontier Capital Management CO LLC holds 179,154 shares of UTHR stock, worth $64.4 Million. This represents 0.64% of its overall portfolio holdings.

Number of Shares

179,154

Previous 37,636 376.02%

Holding current value

$64.4 Million

Previous $12 Million 435.53%

% of portfolio

0.64%

Previous 0.13%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$311.04 - $363.55 $44 Million - $51.4 Million	141,518 Added 376.02%	179,154 $64.2 Million
Q2 2024 Aug 14, 2024	BUY	$228.26 - $319.04 $1.05 Million - $1.47 Million	4,598 Added 13.92%	37,636 $12 Million
Q1 2024 May 15, 2024	SELL	$210.76 - $249.51 $161,442 - $191,124	-766 Reduced 2.27%	33,038 $7.59 Million
Q4 2023 Feb 14, 2024	BUY	$214.88 - $256.94 $8,595 - $10,277	40 Added 0.12%	33,804 $7.43 Million
Q3 2023 Nov 14, 2023	SELL	$211.82 - $248.24 $327,685 - $384,027	-1,547 Reduced 4.38%	33,764 $7.63 Million
Q2 2023 Aug 14, 2023	SELL	$205.19 - $232.99 $5.34 Million - $6.06 Million	-26,021 Reduced 42.43%	35,311 $7.79 Million
Q1 2023 May 15, 2023	SELL	$212.99 - $276.17 $35.2 Million - $45.7 Million	-165,455 Reduced 72.96%	61,332 $13.7 Million
Q4 2022 Feb 14, 2023	BUY	$205.95 - $280.43 $8.17 Million - $11.1 Million	39,657 Added 21.19%	226,787 $63.1 Million
Q3 2022 Nov 14, 2022	SELL	$203.3 - $244.17 $5.19 Million - $6.24 Million	-25,551 Reduced 12.01%	187,130 $39.2 Million
Q2 2022 Jul 20, 2022	BUY	$174.81 - $241.14 $5.8 Million - $8.01 Million	33,203 Added 18.5%	212,681 $50.1 Million
Q1 2022 Apr 14, 2022	SELL	$166.16 - $213.96 $2.81 Million - $3.62 Million	-16,910 Reduced 8.61%	179,478 $32.2 Million
Q4 2021 Jan 19, 2022	BUY	$184.32 - $216.08 $20.1 Million - $23.5 Million	108,924 Added 124.54%	196,388 $42.4 Million
Q3 2021 Oct 19, 2021	SELL	$179.86 - $214.88 $4.07 Million - $4.86 Million	-22,611 Reduced 20.54%	87,464 $16.1 Million
Q2 2021 Aug 09, 2021	SELL	$170.47 - $211.93 $3.18 Million - $3.95 Million	-18,630 Reduced 14.47%	110,075 $19.7 Million
Q1 2021 May 13, 2021	BUY	$153.94 - $174.85 $15.3 Million - $17.4 Million	99,579 Added 341.89%	128,705 $21.5 Million
Q4 2020 Jan 19, 2021	SELL	$101.87 - $151.79 $371,214 - $553,122	-3,644 Reduced 11.12%	29,126 $4.42 Million
Q3 2020 Nov 16, 2020	SELL	$99.9 - $121.13 $1.3 Million - $1.58 Million	-13,023 Reduced 28.44%	32,770 $3.31 Million
Q2 2020 Jul 17, 2020	BUY	$92.74 - $125.82 $572,762 - $777,064	6,176 Added 15.59%	45,793 $5.54 Million
Q1 2020 Apr 16, 2020	BUY	$79.39 - $115.35 $3.15 Million - $4.57 Million	39,617 New	39,617 $3.76 Million

Others Institutions Holding UTHR

# of Institutions

671

Shares Held

42.3M

Call Options Held

194K

Put Options Held

295K

View Full List

About UNITED THERAPEUTICS Corp

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.4B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

More about UTHR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Frontier Capital Management CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Frontier Capital Management CO LLC with notifications on news.

Account

Frontier Capital Management CO LLC United Therapeutics Corp Transaction History